Vuzix Corporation (VUZI)

(A Top Pick Dec 10/20, Up 385%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with VUZI has triggered its stop at $20. To be disciplined, we recommend covering the position. Combined with the previous recommendation to cover 50%, this achieves a combined return on investment of 212%.

(A Top Pick Dec 10/20, Up 525%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with VUZI is progressing well. We are recommending to trail up the stop to $20. This would all but ensure a minimum investment return exceeding 212%, including the recommendation to cover 50% previously.

(A Top Pick Dec 10/20, Up 363%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with VUZI continues to do exceedingly well. We are now recommending to trail the stop up (from $6.00) to $12.50. Back in December we recommended covering half the position. Now if the new stop is triggered, this would all but guarantee a minimum return on investment of 121%.

(A Top Pick Dec 10/20, Up 177.64%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with VUZI is progressing nicely. We now recommend moving up the stop to $6.00 (previously $3.75). This would all but guarantee a minimum return exceeding 42%.

(A Top Pick Dec 10/20, Up 39.5%)Stockchase Research Editor: Michael O'Reilly Our very recent TOP PICK with VUZI has achieved the $5.75 objective. We are recommending to cover 50% of the position. We also recommend trailing up the stop to $3.75 -- just under our initial acquisition recommendation.

Stockchase Research Editor: Michael O'Reilly VUZI produces smart glass for augmented reality uses like "see-through monitors. The pandemic is thought to have accelerated the need for contactless, remote streaming in healthcare by at least a decade. The company is not profitable yet (with recent EPS of <$0.13>; however, right at analyst expectations), but revenues rose over 150% and the company has almost doubled its cash holdings to over $20 million. We would trade this with a stop-loss of $3.00, looking to achieve $5.75 -- 27% upside. Yield 0% (Analysts’ price target is $5.75)